Women in perimenopause experience significantly higher odds of reporting anxiety symptoms than premenopausal women, according to a meta-analysis, with symptoms peaking during the menopausal transition before easing somewhat in the postmenopausal years.
Researchers synthesized observational evidence from 21 peer-reviewed studies involving 24,523 women across multiple countries, publishing their findings in the journal Scientific Reports as detailed in medical reporting from October 2026.
How Anxiety Reporting Shifts Across Reproductive Stages
When researchers pooled the eligible datasets, clear statistical differences emerged between the groups. Women in perimenopause faced 59 percent higher odds of reporting anxiety symptoms compared to their premenopausal counterparts. Postmenopausal women also showed elevated numbers, registering 63 percent higher odds than women before menopause.
The review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, searching databases including Medline, PsycInfo, Embase, and Web of Science through August 16, 2024, using the Critical Appraisal Skills Programme tool to assess study quality. Out of the initial group, 15 studies contributed data to the final meta-analysis comparing anxiety reporting across premenopausal, perimenopausal, and postmenopausal stages among a female population aged 18 and older. The review included studies using standardized anxiety questionnaires, interviews or broader mental-health scales with anxiety items. Following quality assessment, one study rated as low quality was excluded from the meta-analysis, and the researchers pooled eligible datasets using a random-effects meta-analysis with inverse-variance weighting, utilizing baseline observations from longitudinal cohorts alongside cross-sectional studies.
| Menopausal Stage Comparison | Statistical Odds Ratio |
|---|---|
| Perimenopause versus Pre-menopause | OR = 1.59 (95% CI: 1.26-2.00) |
| Post-menopause versus Pre-menopause | OR = 1.63 (95% CI: 1.19–2.25) |
| Post-menopause versus Perimenopause | OR = 0.79 (CI: 0.65–0.96) |
Directly comparing the two later stages demonstrates that the peak occurs during the transition itself. Postmenopausal women exhibited 21 percent lower odds of reporting anxiety symptoms relative to those currently in perimenopause according to pooled observational figures.
Biological Hypotheses and the Limits of Observational Data
Menopause is clinically defined as the permanent cessation of menstrual periods and is determined retrospectively after 12 consecutive months of amenorrhea (absence of menstruation) without any other pathological or physiological cause.
Perimenopausal and postmenopausal women had significantly higher odds of anxiety symptoms compared to their premenopausal counterparts, with the highest odds observed during perimenopause.
The review authors, via News-Medical
Because the pooled research relies primarily on cross-sectional designs and baseline observations from longitudinal cohorts, it remains unproven that menopausal changes directly cause anxiety or that an individual woman’s anxiety inevitably rises as she transitions. To explain these patterns, researchers point to potential biological pathways involving erratic hormonal shifts. Fluctuating estrogen levels can influence central neurotransmitters like serotonin, dopamine, and gamma-aminobutyric acid, while also altering hypothalamic-pituitary-adrenal axis responses to daily stress.
The World Health Organization recognizes anxiety as a potential symptom related to menopause, whereas the United Kingdom’s National Institute for Health and Care Excellence addresses broader psychological symptoms in its guidance but does not explicitly list anxiety as a menopausal indicator based on comparative policy overviews.
Future prospective longitudinal cohorts tracking detailed reproductive substages using uniform measurement scales will be vital for mapping individual symptom trajectories and clarifying underlying mechanisms.
This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.